Exova SL Pharma

Exova SL Pharma is a pharmaceutical company established in 1997, specializing in providing high value and high-quality pharmaceutical CMC product development and full testing services. The company's primary focus is on parenteral and topical drug products, offering a range of services including formulation development, analytical development, microbiological development, and clinical manufacturing for Phase 1 & 2. Exova SL Pharma has built a strong reputation for successfully developing several INDs/NDAs, including 505-b, as well as generic drug products (ANDAs), leading to regulatory approvals and commercialization. Additionally, Exova SL Pharma Labs has played a pivotal role in serving clients and CMOs for the full analytical and microbiological quality control release and stability testing of marketed drug products, notably parenterals. The company prides itself on the highly experienced leadership and competent technical staff, ensuring the delivery of high-quality services with great efficiency and tight timelines at competitive costs. The Pharmaceutical industry-focused company aims to support its clients in meeting product development, analysis, regulatory approval, and commercialization timelines and budgetary requirements, further establishing its position as a reliable partner in the pharmaceutical sector.